SPI Pharma, Inc. and Q-Vant Biosciences, Inc. announce a strategic partnership which includes an investment to expand Q-Vant's proprietary 100% sustainable Q-SAP ™ technology, and the signing of an ...
SPI Pharma, Inc.: Offering broader access to sustainable and scalable pharma-grade saponin adjuvants
SPI Pharma, Inc. and Q-Vant Biosciences, Inc. announce a strategic partnership which includes an investment to expand Q-Vant's proprietary 100% sustainable Q-SAP technology, and the signing of an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback